Market Overview:
The global intrauterine devices (IUDs) market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of unplanned pregnancies, rising awareness about IUDs, and technological advancements in IUD products. The hormonal intrauterine devices (IUDs) segment is expected to grow at a CAGR of 6.0% from 2018 to 2030, owing to the benefits offered by these devices such as reduced menstrual cramps and blood loss, and prevention of endometrial cancer.
 Industry Outlook.svg)
Product Definition:
IUDs are T-shaped devices that are inserted into the uterus to prevent pregnancy. There are two types of IUDs- copper and hormonal. Copper IUDs release copper which interferes with sperm movement and hormone IUDs release progestin, a hormone that thickens the cervical mucus so sperm can't reach the egg. Both types of IUDs are over 99% effective at preventing pregnancy. They can be left in for 3-10 years, depending on the type of IUD.
Hormonal Intrauterine Devices:
Hormonal IUDs are a group of birth control methods that include both hormonal and nonhormonal devices. The most common type of hormonal IUD is the subdermal contraceptive implant, also known as the Jadelle. It is a small plastic device about the size of a matchstick that releases synthetic estrogen and progesterone into your body for about three years.
Copper Intrauterine Devices:
Copper Intrauterine Devices (IUDs) are small devices made up of plastic and copper which is inserted into the uterus through the cervix. It can last for 3 to 6 months, depending upon how often it is used. The IUD market has been growing rapidly over the past few years owing to its effectiveness in preventing pregnancy and reducing menstrual bleeding.
Application Insights:
The clinic application segment held the largest share of more than 60.0% in 2017. The rising number of clinics offering IUDs as an alternative to hormonal methods such as oral contraceptives is one of the key factors driving the market growth. Moreover, increasing awareness about these devices and growing government support are also expected to drive demand over the forecast period.
The hospital application segment is expected to witness a CAGR exceeding 9% from 2018 to 2030 owing to an increase in sterilization procedures performed by hospitals due largelyto high-risk pregnancies and single women¢â‚¬â„¢s health issues being addressed by IUDs particularly copper IUDs owingto their higher efficacy rates over other methods such as hormonal implants or injections, thus leading hospitals towards adopting these devices for sterilization purposes which further drives demand across all regions globally.
Regional Analysis:
Europe dominated the global market in 2017 owing to high product adoption and awareness levels regarding various IUDs. The region is expected to maintain its dominance throughout the forecast period due to increasing demand for long-term contraception. In addition, rising number of women workforce is also a major factor driving growth in Europe.
Asia Pacific intrauterine devices market is anticipated to grow at a lucrative rate over the forecast period owing to increasing government initiatives for family planning and birth control, especially among rural population groups. Moreover, growing awareness about modern contraceptive methods will drive regional growth further on account of rising disposable income level among all sections of society including women themselves which would ultimately increase IUD uptake rates over time as it provides highly effective contraception with low user cost and hassle free usage compared with other modern contraceptives such as injectables or implants that require several visits & injections at clinic premises every three months or so.
Growth Factors:
- Increasing awareness about the benefits of IUDs over other contraceptive methods
- Growing number of women who are choosing to delay childbearing until later in life
- Increased access to IUDs through expanded insurance coverage and government programs
- Advances in technology that have led to the development of new and more effective IUDs
- Greater public acceptance of IUDs as a safe and effective form of contraception
Scope Of The Report
Report Attributes
Report Details
Report Title
Intrauterine Devices (IUDs) Market Research Report
By Type
Hormonal Intrauterine Devices, Copper Intrauterine Devices
By Application
Hospital, Clinic
By Companies
ANI Pharmaceuticals, Allergan, Bayer, Teva Pharmaceutical, Eurogine, HRA Pharma, Medisafe Distribution, OCON Medical, HLL Lifecare, Merck & Co, Besins HealthCare
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
239
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Intrauterine Devices (IUDs) Market Report Segments:
The global Intrauterine Devices (IUDs) market is segmented on the basis of:
Types
Hormonal Intrauterine Devices, Copper Intrauterine Devices
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- ANI Pharmaceuticals
- Allergan
- Bayer
- Teva Pharmaceutical
- Eurogine
- HRA Pharma
- Medisafe Distribution
- OCON Medical
- HLL Lifecare
- Merck & Co
- Besins HealthCare
 Market Overview.svg)
Highlights of The Intrauterine Devices (IUDs) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Hormonal Intrauterine Devices
- Copper Intrauterine Devices
- By Application:
- Hospital
- Clinic
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Intrauterine Devices (IUDs) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Intrauterine devices (IUDs) are a type of birth control that is inserted into the uterus by a doctor. IUDs work by preventing sperm from fertilizing an egg. They can be used for up to 10 years and may prevent pregnancy in up to 99% of cases.
Some of the major players in the intrauterine devices (iuds) market are ANI Pharmaceuticals, Allergan, Bayer, Teva Pharmaceutical, Eurogine, HRA Pharma, Medisafe Distribution, OCON Medical, HLL Lifecare, Merck & Co, Besins HealthCare.
The intrauterine devices (iuds) market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Intrauterine Devices (IUDs) Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Intrauterine Devices (IUDs) Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Intrauterine Devices (IUDs) Market - Supply Chain
4.5. Global Intrauterine Devices (IUDs) Market Forecast
4.5.1. Intrauterine Devices (IUDs) Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Intrauterine Devices (IUDs) Market Size (000 Units) and Y-o-Y Growth
4.5.3. Intrauterine Devices (IUDs) Market Absolute $ Opportunity
5. Global Intrauterine Devices (IUDs) Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Intrauterine Devices (IUDs) Market Size and Volume Forecast by Type
5.3.1. Hormonal Intrauterine Devices
5.3.2. Copper Intrauterine Devices
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Intrauterine Devices (IUDs) Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Intrauterine Devices (IUDs) Market Size and Volume Forecast by Application
6.3.1. Hospital
6.3.2. Clinic
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Intrauterine Devices (IUDs) Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Intrauterine Devices (IUDs) Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Intrauterine Devices (IUDs) Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Intrauterine Devices (IUDs) Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Intrauterine Devices (IUDs) Demand Share Forecast, 2019-2026
9. North America Intrauterine Devices (IUDs) Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Intrauterine Devices (IUDs) Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Intrauterine Devices (IUDs) Market Size and Volume Forecast by Application
9.4.1. Hospital
9.4.2. Clinic
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Intrauterine Devices (IUDs) Market Size and Volume Forecast by Type
9.7.1. Hormonal Intrauterine Devices
9.7.2. Copper Intrauterine Devices
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Intrauterine Devices (IUDs) Demand Share Forecast, 2019-2026
10. Latin America Intrauterine Devices (IUDs) Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Intrauterine Devices (IUDs) Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Intrauterine Devices (IUDs) Market Size and Volume Forecast by Application
10.4.1. Hospital
10.4.2. Clinic
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Intrauterine Devices (IUDs) Market Size and Volume Forecast by Type
10.7.1. Hormonal Intrauterine Devices
10.7.2. Copper Intrauterine Devices
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Intrauterine Devices (IUDs) Demand Share Forecast, 2019-2026
11. Europe Intrauterine Devices (IUDs) Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Intrauterine Devices (IUDs) Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Intrauterine Devices (IUDs) Market Size and Volume Forecast by Application
11.4.1. Hospital
11.4.2. Clinic
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Intrauterine Devices (IUDs) Market Size and Volume Forecast by Type
11.7.1. Hormonal Intrauterine Devices
11.7.2. Copper Intrauterine Devices
11.8. Basis Point Share (BPS) Analysis by Type
11.9. -o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Intrauterine Devices (IUDs) Demand Share, 2019-2026
12. Asia Pacific Intrauterine Devices (IUDs) Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Intrauterine Devices (IUDs) Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Intrauterine Devices (IUDs) Market Size and Volume Forecast by Application
12.4.1. Hospital
12.4.2. Clinic
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Intrauterine Devices (IUDs) Market Size and Volume Forecast by Type
12.7.1. Hormonal Intrauterine Devices
12.7.2. Copper Intrauterine Devices
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Intrauterine Devices (IUDs) Demand Share, 2019-2026
13. Middle East & Africa Intrauterine Devices (IUDs) Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Intrauterine Devices (IUDs) Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Intrauterine Devices (IUDs) Market Size and Volume Forecast by Application
13.4.1. Hospital
13.4.2. Clinic
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Intrauterine Devices (IUDs) Market Size and Volume Forecast by Type
13.7.1. Hormonal Intrauterine Devices
13.7.2. Copper Intrauterine Devices
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Intrauterine Devices (IUDs) Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Intrauterine Devices (IUDs) Market: Market Share Analysis
14.2. Intrauterine Devices (IUDs) Distributors and Customers
14.3. Intrauterine Devices (IUDs) Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. ANI Pharmaceuticals
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Allergan
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Bayer
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Teva Pharmaceutical
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Eurogine
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. HRA Pharma
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Medisafe Distribution
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. OCON Medical
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. HLL Lifecare
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Merck & Co
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Besins HealthCare
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
